Vaxcyte (PCVX) announced it has appointed Dr. Olivier Brandicourt, a veteran biopharmaceutical industry executive and the former Chief Executive Officer of Sanofi (SNY), to its Board of Directors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PCVX:
- Vaxcyte initiated with an Overweight at Cantor Fitzgerald
- Biotech Alert: Searches spiking for these stocks today
- Vaxcyte’s Promising Prospects: Buy Rating Reinforced by Positive Phase 2 Data and Strategic Expansion
- Optimistic Buy Rating for Vaxcyte Amid Vaccine Development Challenges and Strategic Adjustments
- BofA lowers Vaxcyte price target, says selloff after infant data ‘overdone’